ClinicalTrials.gg
RecruitingNCT07495826PRoSEEDUpdated Sep 18, 2026

PRedictors Of Maladaptive Behaviors in Children Undergoing Procedural SEDation

An observational study in Procedural Sedation and Analgesia, sponsored by London Health Sciences Centre Research Institute. Recruiting at 2 sites in Canada. Open to participants aged 1 Year to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by London Health Sciences Centre Research Institute · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,145
Ages
1 Year to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 461 studies in Pain with a site in Canada — 62 open to participants now, 66 under way, 1 of them phase 3. Pain · Canada.

Planned enrollment
5th of 42
2,145 · median 153
Started
2026
with 15 others
Observational
42 of 461
10 open now
Primary completion
2029-12
later than 64 of 65 live
Registered
452nd of 461
by date

Among the 461 studies in Pain with a site in Canada, this one is the 5th largest by planned enrollment of the 42 observational ones that give a count, is one of 16 that started in 2026, is one of 42 observational ones, reaches primary completion later than 64 of the 65 other live ones, and was the 452nd registered.

Pain

10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.

Browse Pain studies →

Open to participants now

62 of the 461 studies in Pain with a site in Canada are open now. Recruiting first, the newest first:

56 more — sign in →

All 62 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.

This study: 1 Year to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 461 studies in Pain with a site in Canada, or all of them as a file.
02

Study summary

Procedural sedation for children outside of the operating room is a common practice in emergency departments, outpatient clinics, radiology suites, and dental offices for painful and anxiety-provoking procedures. However, there is emerging evidence that so-called "delayed maladaptive behaviors" (disordered sleep, anxiety, and aggression) affect nearly a quarter of children for up to 2 weeks following sedation. This can lead to poor school attendance, reduced extracurricular involvement, disruptions to caregivers' employment obligations, and poor patient satisfaction. As this phenomenon has only recently been identified, very little is known about what factors predispose children to delayed maladaptive behaviors, however, small studies suggest younger age and pre-procedural anxiety may be involved. The aim of our study is to characterize risk factors for delayed maladaptive behavior in a large multicentre study involving emergency departments, dental offices, and hospital sedation services. Understanding these risk factors may help healthcare workers prevent delayed maladaptive behaviors and provide patients with anticipatory guidance, akin to post-operative recovery instructions.

There is emerging evidence that maladaptive behaviors, including significant negative behavioral changes, can occur in children following procedural sedation. These include disordered sleep, anxiety, and aggression)1,2 and affect up to 24% of children following inhalational anesthetics3 and intravenous sedatives such as ketamine.1 Moreover, these appear to be more pronounced in children \<4 years4 and can persist for up to 2 weeks post-sedation. Unfortunately, only two trials have reported delayed maladaptive behaviors.1,2 Data on immediate and delayed AEs are urgently needed for safe clinical decision-making and anticipatory guidance surrounding ED anxiolytics. In a prospective cohort study of children undergoing emergency department procedural sedation with intravenous ketamine, 22% exhibited significant negative behavioral changes 1-2 weeks after discharge, as measured by the Post-Hospitalization Behavior Questionnaire. High pre-procedure anxiety have been identified as independent predictors of these maladaptive behaviors.5 Additionally, irritability, hyperactivity, and hallucinations during recovery have been reported and are associated with lower parental satisfaction.6

Read the detailed description

RESEARCH QUESTION What are the risk factors for delayed maladaptive behaviors in children and adolescents 1-17 years undergoing procedural sedation or anxiolysis?

OBJECTIVES i) Characterize the risk factors associated with delayed maladaptive behaviors in children undergoing procedural sedation or anxiolysis in the ED and dental clinics.

ii) Determine the proportion of children with delayed maladaptive behaviors following procedural sedation or anxiolysis.

iii) Determine the degree to which delayed maladaptive behaviors are associated with post-sedation pain.

HYPOTHESES i) An increased risk of delayed maladaptive behaviors (> 3 in negative behaviors score from pre-sedation to 3-days post-sedation) will be associated with younger age, greater pre-sedation anxiety (Modified Yale Pre-Operative Anxiety Scale score > 40), greater pre-sedation pain (Parent's Post-Operative Pain Measure - Short Form), sedative drug combinations, and baseline temperament (Integrative Childhood Temperament Screener - age \< 8 years) and Integrative Late Childhood Temperament Inventory - age > 8 years). This hypothesis is based on previous associations identified in children receiving inhalational anesthetics.7-9 ii) The proportion of children with delayed maladaptive behaviors will be > 20% based on prior literature.5,10 iii) Delayed maladaptive behaviors will be associated with greater post-sedation pain.

BACKGROUND Procedural sedation in children outside of the operating room (OR) is routinely performed for orthopedic reductions, laceration repairs, diagnostic imaging, and other painful or anxiety-provoking procedures.[3-6] Data from the Pediatric Sedation Research Consortium identified 432,842 outpatient pediatric procedural sedation encounters over an 11-year period, reflecting widespread use in settings such as emergency departments (EDs), radiology suites, and dedicated sedation units.14,15 Most sedations are performed in children under 10 years of age.[3-4] Ketamine is the most commonly used agent,16 but other common sedatives include propofol, nitrous oxide, and dexmedetomidine.15,17 Children also receive anxiolysis (nitrous oxide; midazolam) for procedural distress. Typically, these agents do not sedative children but may be associated with delayed maladaptive behaviors.

Although procedural sedation outside the OR is widely regarded as safe,18-20 there is emerging evidence that delayed maladaptive behaviors, manifesting as disordered sleep, separation anxiety, and aggression towards authority2,5 can affect up to a third of children.5,10,21 Delayed maladaptive behaviors have been described following general anesthesia in the perioperative setting,7,8 where they can persist for up to a month post-anesthesia.8 Moreover, they appear to be more pronounced in children under 4 years of age.7 However, only two studies have characterized delayed maladaptive behaviors following procedural sedation outside the OR.2,5 A prospective single-center study of 97 children undergoing ED procedural sedation with intravenous ketamine found that 22% of children exhibited significant negative behavioral changes up to 2 weeks after discharge with high pre-procedural anxiety identified as a risk factor.5 Another study of 60 children found that 20% exhibited delayed maladaptive behaviors that persisted for one week following ED discharge.10

Although there are similarities between the ED and perioperative setting, there are some important differences. Unlike the OR, procedural sedation in the ED is largely unscheduled, and with a relatively short time period from decision to performance of the procedure. This together with the time constraints of busy EDs often precludes the ability of healthcare workers to enact measures to reduce pre-procedural anxiety and provide anticipatory guidance to families. In addition, procedural sedation in the ED is often performed to facilitate low morbidity procedures with an anticipated short recovery time. In contrast to surgical procedures in the OR, children are often expected to resume normal activities shortly after an ED visit. Thus, the frequency, severity, and functional impact of delayed maladaptive behaviors on children and their caregivers may be significantly greater.

RATIONALE AND SIGNIFICANCE Procedural sedation and anxiolysis is frequently performed in children and preliminary evidence suggests delayed maladaptive behaviors are common. These behaviors may reduce school attendance and participation in extracurricular activities and compromise caregivers' abilities to fulfill employment responsibilities. Characterizing the risk factors for delayed maladaptive is essential to extending the care of children and supporting their caregivers following ED discharge. The Canadian Paediatric Society (CPS) strongly recommends managing distress during medical procedures, but lacks guidance for pre-sedation pain and anxiety,22 which may contribute to delayed maladaptive behaviors. Our study will fill this unmet need and identify modifiable risk factors such as pain and pre-procedural anxiety that can be addressed through interventions by certified child life specialists (CCLSs) and bedside nurses. Currently, measures to reduce anxiety and pain-related procedural distress in children are inconsistently used.23,24 Our findings will also inform more comprehensive amendments to existing pain and anxiety management recommendations set by the CPS.22

Characterizing risk factors for delayed maladaptive behaviors in children undergoing procedural sedation or anxiolysis is highly innovative because current research has focused primarily on immediate adverse events and neurodevelopmental outcomes, leaving a significant gap in understanding the behavioral sequelae of procedural sedation outside the OR.6,20,25,26 Recent large-scale studies have identified risk factors for acute adverse events and prolonged recovery, such as higher body weight, prior sedation history, and specific sedative agents, but have not systematically addressed delayed maladaptive behavioral changes.17,20 The American Academy of Pediatrics highlighted the need for further work to determine the magnitude and causation of behavioral and executive function deficits in children with repeated sedation exposures, especially those with developmental disabilities.27 Our work will fill this unmet need. Moreover, parental dissatisfaction and negative recovery experiences are associated with behavioral symptoms that persist into the post-sedation period, yet these outcomes remain poorly characterized in the literature.6 By prospectively identifying modifiable and non-modifiable risk factors for delayed maladaptive behaviors, this study will address critical knowledge gaps and inform safer, more personalized sedation practices for children and adolescents.

EXPECTED OUTCOMES Overall, the study is expected to provide actionable data on modifiable and non-modifiable risk factors for maladaptive behavioral outcomes with the overarching aim of informing safer and more personalized sedation practices in children. In the short-term, we expect to characterize risk factors that increase the risk for delayed maladaptive behaviors in children and adolescents undergoing procedural sedation or anxiolysis, identify the prevalence of maladaptive behaviors, and identify links with post-sedation pain. In the long-term, we expect to use this knowledge to implement practice change through i) education of certified child life specialist and nurses on the importance of measures to reduce pre-procedural anxiety such as providing age-appropriate anticipatory guidance, distraction, and caregiver involvement; ii) education of physicians on the importance of screening for at-risk patients and choosing sedative or anxiolytic and doses that are associated with a lower risk of maladaptive behaviors; iii) standardizing pre-procedural analgesia through nurse-initiated medical directives for common indications such as orthopedic manipulation, laceration repair, and dental procedures. We will evaluate the impact of the study's findings using a quality improvement (QI) framework.

03

Conditions studied

  • Procedural Sedation and Analgesia

Browse trials for

Keywords

  • procedural sedation
  • pediatrics
  • maladaptive behavior
  • pain
04

Who can participate

Ages eligible
1 Year to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Children and adolescents 1-17 years undergoing procedural sedation or anxiolysis with any agent for any indication in the ED and dental clinics

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents 1-17 years undergoing procedural sedation or anxiolysis with any agent for any indication in the ED and dental clinics

Exclusion criteria

Exclusion Criteria:

  • Patients where the primary caregiver lacks English or French (if applicable to site) comprehension in the absence of a native language interpreter
  • Lack a smartphone able to receive SMS text messages
  • Caregiver and/or patient are not available for all of the planned follow-up dates
  • Previously enrolled in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,145 participants (estimated)
Patient registry
No

Groups and cohorts

  • Procedural sedation or anxiolysis

    Children and adolescents 1-17 years undergoing procedural sedation or anxiolysis with any agent for any indication in the ED and dental clinics.

06

What researchers measure

Primary outcomes

  1. Post-Hospital Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS)

    The PHBQ-AS is a caregiver-reported 11-item measure of post-hospitalization behavioral changes. The PHBQ-AS is a revision of the original PHBQ with 11 items, no subscales, and a different scoring approach that treats behavioral change as a continuous overall construct, based on average item scores, rather than relying on a count of "severe" behaviors or a threshold meant to imply clinical severity. To score the PHBQ-AS, items are averaged by summing the items for each respondent and dividing by the total number of items. The total PHBQ-AS score produces a continuous variable with higher values above 3 (the midpoint) indicating greater maladaptive behavioral changes, lower values below 3 indicating improvements in behavioral change, and values equal to 3 indicating no behavioral change. A cut-off score of 3.2 on the PHBQ-AS for the diagnosis of negative behavior has been published.33 The original PHBQ was designed to measure behavior changes after surgery or hospitalization, and has be

    Time frame: 3 days

Secondary outcomes

  1. PHBQ

    Prevalence of maladaptive behaviors on days 1, 7, 10, and 14 post-sedation or anxiolysis based on a significant deterioration ((\> 3.2 negative changes on the PHBQ-AS).31)

    Time frame: Days 1, 7, 10, and 14

07

Study locations

2 of 2 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — This was not specified in the ethics application.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2029, 45 months after the start.

Of 504 non-industry observational studies under Pain, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's planned 45 months is above that.

Counting every sponsor, half of 519 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2026
First posted
Mar 27, 2026
StartActual
Mar 18, 2026
Primary completionEst.
Dec 31, 2029
CompletionEst.
May 30, 2030
Last update
Sep 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07495826
Lead sponsor
London Health Sciences Centre Research Institute
Responsible party
Naveen Poonai (Principal Investigator, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's) — Principal investigator
First posted
Mar 27, 2026
Start date
Mar 18, 2026
Primary completion
Dec 31, 2029 (estimated)
Completion
May 30, 2030 (estimated)
Last update
Sep 18, 2026

Study contacts

Naveen Poonai Principal Investigator
Contact
naveen.poonai@lhsc.on.ca
5196945309
Naveen Poonai, MD MSc
principal investigator · Western University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion